Conditional restriction
In competition: injectable, oral/oromucosal and rectal routes are prohibited; other routes have conditions.
Read the primary source · S9 · page 19 ↗Conditions change the answer.
Read the linked section in full. The summary above does not encode every exception, route, combination, timing or sport-specific condition.
The 2027 List explicitly includes vaginal administration among routes subject to the licensed-dose and therapeutic-indication exception. This forthcoming change is not an individualized clearance.
What about a Therapeutic Use Exemption?
A TUE is an individual authorization process. A prescription alone does not establish an exemption. Requirements and recognition depend on the relevant anti-doping authority. Discuss necessary treatment and documentation with your clinician and that authority.
Read the applicable ISTUE ↗Mechanism ≠ proof of performance.
This prototype does not infer mechanism, performance benefit or medical usefulness from prohibition status. A claim-level literature review is required before those sections are published.
Risk deserves its own evidence.
A complete safety assessment has not yet been prepared. Missing risk information does not establish safety.
Do not change necessary treatment based on this prototype. Speak with a qualified healthcare professional.
Follow the source.
- Official regulationWADA · 2026 Prohibited List↗
- Official standardWADA · ISTUE · effective 2023↗
- Forthcoming regulationWADA · 2027 List · 4 November revision↗